Epidemiology, Achievements, and Challenges in the Elimination of Hepatitis B in China (IMAGE)
Caption
China has achieved remarkable success in reducing HBV prevalence through evidence-based interventions, including universal infant HepB vaccination, MTCT prevention, and expanded healthcare access. Achieving the WHO’s 2030 targets will require further strengthening of large-scale testing, early treatment, and long-term follow-up programs, as well as advancing innovative therapies and ensuring equitable healthcare delivery nationwide. With sustained investment and continued innovation, the elimination of hepatitis B as a public health threat is within reach, offering valuable insights and experience for global HBV control efforts
Credit
Yu Wang, Jidong Jia
Usage Restrictions
Credit must be given to the creator. Only noncommercial uses of the work are permitted.
License
CC BY-NC